ICD-10 Coding for Positive Human Papillomavirus(B97.7P, B97.7U, R87.610)
Learn about ICD-10 coding for positive human papillomavirus, including documentation requirements and billing considerations for high-risk HPV tests.
Complete code families applicable to Positive Human Papillomavirus
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R87.810 | Cervical high-risk human papillomavirus (HPV) DNA test positive | Use when a high-risk HPV DNA test is positive for a cervical specimen. |
|
| R87.811 | Vaginal high-risk human papillomavirus (HPV) DNA test positive | Use when a high-risk HPV DNA test is positive for a vaginal specimen. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPositive Human Papillomavirus
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Positive Human Papillomavirus.
Failing to specify high-risk HPV in documentation
Impact
Clinical: May lead to inappropriate follow-up care., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Train staff on documentation requirements., Use templates that prompt for specific details.
Using R87.810 for a vaginal HPV test result
Impact
Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation
Use R87.811 for vaginal high-risk HPV test results.
Documentation Accuracy
Impact
Risk of audits due to insufficient documentation of HPV test details.
Mitigation
Implement standardized documentation templates.